Literature DB >> 18709545

Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic control.

A V Bernier1, C P Sentner, C E Correia, D W Theriaque, J J Shuster, G P A Smit, D A Weinstein.   

Abstract

While the presence of hyperlipidaemia in glycogen storage disease (GSD) type Ia and Ib is generally accepted, few investigators have adequately assessed lipid profiles of GSD III in children, in whom the presence of hyperlipidaemia may be most prominent. We analysed the lipid profiles in 44 GSD III patients from 6 months to 30 years of age. Hypertriglyceridaemia and hypercholesterolaemia were common in children younger than 3 years of age. Hypertriglyceridaemia correlated negatively with age, and may reflect increased severity of hypoglycaemia in this younger population. The presence of hyperlipidaemia during childhood in these patients identifies another GSD population that could be at risk for early cardiovascular disease (CVD). Consequently, the outcome of clinical trials investigating the vascular effect of hyperlipidaemia in GSD applies to types other than GSD I.

Entities:  

Mesh:

Year:  2008        PMID: 18709545      PMCID: PMC3832627          DOI: 10.1007/s10545-008-0919-5

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  8 in total

Review 1.  Glycogen storage diseases.

Authors:  Joseph I Wolfsdorf; David A Weinstein
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients.

Authors:  Andrew D Nguyen; Chi-Jiunn Pan; David A Weinstein; Janice Y Chou
Journal:  Mol Genet Metab       Date:  2006-06-14       Impact factor: 4.797

3.  Serum lipid and lipoprotein profile of patients with glycogen storage disease types I, III and IX.

Authors:  T Geberhiwot; S Alger; P McKiernan; C Packard; M Caslake; E Elias; R Cramb
Journal:  J Inherit Metab Dis       Date:  2007-04-03       Impact factor: 4.982

4.  Is glycogen storage disease 1a associated with atherosclerosis?

Authors:  Froukje L Ubels; Jan Peter Rake; Joris P J Slaets; G Peter A Smit; Andries J Smit
Journal:  Eur J Pediatr       Date:  2002-07-02       Impact factor: 3.183

5.  Blood lipids and endothelial function in glycogen storage disease type III.

Authors:  E Hershkovitz; A Donald; M Mullen; P J Lee; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1999-12       Impact factor: 4.982

6.  Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a.

Authors:  Robert H J Bandsma; Berthil H Prinsen; Monique de Sain van Der Velden; Jan-Peter Rake; Theo Boer; G Peter A Smit; Dirk-Jan Reijngoud; Folkert Kuipers
Journal:  Pediatr Res       Date:  2008-06       Impact factor: 3.756

7.  Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia.

Authors:  Birgit Wittenstein; Marcus Klein; Barbara Finckh; Kurt Ullrich; Alfried Kohlschütter
Journal:  Free Radic Biol Med       Date:  2002-07-01       Impact factor: 7.376

8.  Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type Ia.

Authors:  C Mühlhausen; R Schneppenheim; U Budde; M Merkel; N Muschol; K Ullrich; R Santer
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.750

  8 in total
  7 in total

Review 1.  Targeting glycogen metabolism in bladder cancer.

Authors:  Carolyn Ritterson Lew; Sunny Guin; Dan Theodorescu
Journal:  Nat Rev Urol       Date:  2015-05-26       Impact factor: 14.432

2.  Natural history of hepatocellular adenoma formation in glycogen storage disease type I.

Authors:  David Q Wang; Laurie M Fiske; Caroline T Carreras; David A Weinstein
Journal:  J Pediatr       Date:  2011-04-09       Impact factor: 4.406

3.  Markedly elevated serum transaminases in glycogen storage disease type III.

Authors:  Christine Karwowski; Csaba Galambos; David Finegold; Benjamin L Shneider
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-05       Impact factor: 2.839

4.  Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism.

Authors:  Sakine Sever; David A Weinstein; Joseph I Wolfsdorf; Reyhan Gedik; Ernst J Schaefer
Journal:  J Clin Lipidol       Date:  2012-08-30       Impact factor: 4.766

5.  Case report on an infant presenting with hypoglycemia, and milky serum.

Authors:  Yogesh Kumar Gupta; Anushre Prasad; Pushpa Kini; Prashant Naik; Deepti Choprra; Krishnananda Prabhu
Journal:  Asian Pac J Trop Biomed       Date:  2012-04

6.  Characterization of a canine model of glycogen storage disease type IIIa.

Authors:  Haiqing Yi; Beth L Thurberg; Sarah Curtis; Stephanie Austin; John Fyfe; Dwight D Koeberl; Priya S Kishnani; Baodong Sun
Journal:  Dis Model Mech       Date:  2012-06-26       Impact factor: 5.758

Review 7.  Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions.

Authors:  Terry G J Derks; Margreet van Rijn
Journal:  J Inherit Metab Dis       Date:  2015-01-30       Impact factor: 4.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.